. Author manuscript; available in PMC: 2014 Jul 15.

Published in final edited form as: J Pediatr Gastroenterol Nutr. 2014 May;58(5):569–573. doi: 10.1097/MPG.0000000000000277

TABLE 1.

Baseline characteristics

Male sex, n, %	259	52.0
White race, n, %	455	91.2
Infliximab use, n, %	152	30.5
Clinically significant depressive symptoms, n, %	190	38.1
Disease location
Terminal ileum ± limited cecal, n, %	72	15.9
Colonic, n, %	69	15.2
Ileocolonic, n, %	306	67.4
Upper GI proximal to ligament of Treitz, n, %	304	69.4
Distal to ligament of Treitz to prozimal ileum, n, %	44	11.5
History of ostomy, n, %	8	1.6
History of IBD-related surgery, n, %	44	8.8
Age (mean years, SD)	14.4	2.6
SES, mean, SD	1.35	0.61
CDIT, mean, SD	14.8	12.3
PCDAI, mean, SD	13.4	14.2
Yearly steroid load, mean mg · kg⁻¹ · y⁻¹, SD	17.0	25.0
Daily steroid dose, mean mg · kg⁻¹ · y⁻¹, SD	0.1	0.3
ESR, mean mm/h, SD	19.1	15.2
Duration of disease, mean years, SD	2.3	2.5

CDIT = total Children’s Depression Inventory; ESR = erythrocyte sedimentation rate; GI = gastrointestinal; IBD = inflammatory bowel disease; PCDAI = Pediatric Crohn Disease Activity Index; SD = standard deviation; SES = socioeconomic status.